Protalix Biotherapeutics Inc. buy melinda
Start price
02.06.16
/
50%
€6.96
Target price
02.12.16
€12.00
Performance (%)
-22.13%
End price
02.12.16
€5.42
Summary
This prediction ended on 02.12.16 with a price of €5.42. The price of Protalix Biotherapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -22.13%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Protalix Biotherapeutics Inc. | 0.000% | 0.000% | -16.074% | 15.385% |
| iShares Core DAX® | -1.933% | 2.239% | 16.921% | 61.658% |
| iShares Nasdaq 100 | -0.972% | 0.226% | 5.003% | 104.644% |
| iShares Nikkei 225® | -2.056% | 5.685% | 19.218% | 51.355% |
| iShares S&P 500 | -1.185% | 0.867% | 2.378% | 66.527% |
According to melinda what are the pros and cons of Protalix Biotherapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Protalix Biotherapeutics Inc. diskutieren
(Laufzeit überschritten)
Stopped prediction by melinda for Protalix Biotherapeutics Inc.
Protalix Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€1.56
28.12.25
28.12.25
-
28.12.26
28.12.26
-1.28%
03.01.26
03.01.26
Could be worthwhile Investment >10% per year
Protalix Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€1.63
27.12.23
27.12.23
€2.00
27.12.24
27.12.24
9.02%
28.12.24
28.12.24
Protalix Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€7.24
17.05.17
17.05.17
€9.00
25.05.17
25.05.17
12.85%
25.05.17
25.05.17
Protalix Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€32.52
23.09.13
23.09.13
€40.00
24.03.14
24.03.14
2.15%
24.03.14
24.03.14